Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 44035 [2014-17804]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: July 15, 2014.
Richard Kronick,
AHRQ Director.
BILLING CODE 4160–90–M
[FR Doc. 2014–17737 Filed 7–28–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
rmajette on DSK2TPTVN1PROD with NOTICES
Time and Date
10:00 a.m.–11:30 a.m. EDT, August
19, 2014.
PLACE: Teleconference.
STATUS: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment period, which is
tentatively scheduled from 11:20 to
11:30 a.m. To participate on the
teleconference, please dial (866) 763–
0273 and enter code 6158968.
PURPOSE: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
MATTERS FOR DISCUSSION: The Health
Disparities Subcommittee (HDS)
members will discuss progress to date
on the recommendations approved by
the CDC ACD in April 2014 and review
updates on previously established
priorities of the HDS.
The agenda is subject to change as
priorities dictate.
Jkt 232001
Center Parkway, Atlanta, Georgia 30345,
Telephone: (404) 498–6185.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–17804 Filed 7–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
15:02 Jul 28, 2014
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30333. Telephone (770) 488–
8182, Email: LEL1@cdc.gov. The
Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–17660 Filed 7–28–14; 8:45 am]
VerDate Mar<15>2010
CONTACT PERSON FOR MORE INFORMATION:
44035
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings; Board of Scientific
Counselors, Office of Infectious
Diseases (BSC, OID)
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the NIOSH Assessment of
Elastomeric Respirators in Healthcare
Environments, RFA–OH–14–009, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date
1:00 p.m.–4:00 p.m., August 20, 2014
(Closed)
PLACE: Teleconference
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
MATTERS FOR DISCUSSION: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to the
‘‘NIOSH Assessment of Elastomeric
Respirators in Healthcare Environments,
RFA–OH–14–009.’’
CONTACT PERSON FOR MORE INFORMATION:
Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 2400 Century
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Time and Date
1:00–3:00 p.m. EDT, August 19, 2014
Place: Teleconference.
Status: The meeting is open to the
public; the toll free dial in number is 1–
877–951–7311 with a pass code of
7634914.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: The following
topics will be discussed: (1) reports back
from the May 2014 BSC, OID, working
group meetings and (2) an update from
OID on recent outbreak responses and
national center priorities.
The agenda and any supplemental
material will be available at
www.cdc.gov/oid/BSC.html after August
10.
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 79, Number 145 (Tuesday, July 29, 2014)]
[Notices]
[Page 44035]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17804]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns the NIOSH Assessment of
Elastomeric Respirators in Healthcare Environments, RFA-OH-14-009,
initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date
1:00 p.m.-4:00 p.m., August 20, 2014 (Closed)
Place: Teleconference
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial review,
discussion, and evaluation of applications received in response to the
``NIOSH Assessment of Elastomeric Respirators in Healthcare
Environments, RFA-OH-14-009.''
Contact Person for More Information: Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 2400 Century Center Parkway, Atlanta, Georgia
30345, Telephone: (404) 498-6185.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-17804 Filed 7-28-14; 8:45 am]
BILLING CODE 4163-18-P
